Clinical Trials Directory

Trials / Completed

CompletedNCT00271401

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

A Multicenter, Randomized Trial Evaluating 30-day and 6-month Clinical Outcomes With Three Different Treatment Strategies (Coronary Angioplasty + Abciximab, Intracoronary Stent + Abciximab, and Intracoronary Stent + Placebo) in Patients Undergoing Percutaneous Coronary Intervention

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
2,399 (actual)
Sponsor
Centocor, Inc. · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effectiveness and safety of intracoronary stenting with or without abciximab, an anti-platelet therapy, and conventional coronary angioplasty with abciximab in patients undergoing percutaneous coronary intervention.

Detailed description

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and effectiveness of intracoronary stenting with or without abciximab, an anti-platelet therapy, and conventional coronary angioplasty with abciximab in patients undergoing percutaneous coronary intervention. Patients will be randomly assigned to one of three treatment groups: coronary angioplasty plus abciximab, intracoronary stent plus abciximab, or intracoronary stent plus placebo. The primary measures of effectiveness will be a 30-day composite, clinical outcome as determined by the number of deaths, myocardial infarctions, or urgent repeat revascularizations. Please see attached results. Patients will receive one of three different treatments: Coronary angioplasty plus abciximab; Intracoronary stent plus abciximab; or Intracoronary stent plus placebo.

Conditions

Interventions

TypeNameDescription
OTHERAngioplasty
OTHERIntracoronary Stent
DRUGAbxicimab
DRUGHeparin
DRUGPlacebo

Timeline

Start date
1996-07-01
Primary completion
1997-09-01
Completion
1997-09-01
First posted
2006-01-02
Last updated
2015-05-25

Source: ClinicalTrials.gov record NCT00271401. Inclusion in this directory is not an endorsement.